Infectious Disease

People with lower levels of an antiviral antibody as well as those with lung disease take longer to clear COVID-19 symptoms, say Stanford Medicine researchers.

Levels of a stringy, spongy substance soar in the sputum of COVID-19 patients requiring intubation, accounting for at least some of their breathing trouble. Development of an off-patent drug may prevent it.

Stanford Medicine now provides a test for the monkeypox virus. Rapid identification of infected people will help combat the virus’s spread and facilitate patient care.

Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.

Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.

People with mild to moderate COVID-19 can shed viral RNA in their feces months after initial infection, Stanford researchers find. Those who do often have nausea, vomiting and abdominal pain.

Using household items, Stanford students have developed a way to make affordable nasal drops with the potential to slow the spread of viruses like COVID-19.

Two-dose COVID-19 vaccines significantly increase protection against hospitalization and death in people who had the illness before they were immunized.

Researchers have created a test that can predict which dengue patients will likely have mild symptoms and which should be clinically monitored for a high risk of severe illness.

Stanford Medicine scientists explain what we know, and what we don’t know, about living with COVID-19 two years after the World Health Organization declared a pandemic.

Tuberculosis lesions in the lungs have high levels of proteins that suppress the immune system. Cancer drugs that target these proteins could be used to fight the bacterial infection.